| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/28/2007 | US20070149448 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media |
| 06/28/2007 | US20070149441 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| 06/28/2007 | US20070148437 Thermosensitive, biocompatible polymer carriers with changeable physical structure for therapy, diagnostics and analytics |
| 06/28/2007 | US20070148325 Multi-nozzle for granulation and method for manufacturing granular product |
| 06/28/2007 | US20070148264 Agent for the prevention and/or treatment of septicemia |
| 06/28/2007 | US20070148263 comprises curcumin and an essential oil of turmeric |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148255 Compositions for delivery of drug combinations |
| 06/28/2007 | US20070148254 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 06/28/2007 | US20070148253 Modified Release Formulation of Lithium Carbonate and Method for Preparation Thereof |
| 06/28/2007 | US20070148252 Solid stabilized particles comprising ganaxolone, a hydrophilic polymer (cellulose, polyvinyl alcohol), a wetting agent (sodium lauryl sulfate), a complexing agent (benzoic acid, parabens) that stabilizes particle growth after an initial particle growth and endpoint is reached |
| 06/28/2007 | US20070148251 Nanoparticle releasing medical devices |
| 06/28/2007 | US20070148250 Loading of a camptothecin drug into colloidal nanoparticles |
| 06/28/2007 | US20070148249 Method of preparation of oral solid dosage form with instant release of acting |
| 06/28/2007 | US20070148248 Gastric reflux resistant dosage forms |
| 06/28/2007 | US20070148247 Pharmaceutical composition which reduces or eliminates drug abuse potential |
| 06/28/2007 | US20070148246 Nucleic Acid-Based Matrixes |
| 06/28/2007 | US20070148245 Compressed solid dosage forms with drugs of low solubility and process for making the same |
| 06/28/2007 | US20070148244 Drug delivery systems |
| 06/28/2007 | US20070148243 Containment of a treatment agent in a body vessel |
| 06/28/2007 | US20070148242 Preparation for repairing cartilage tissue, especially articular cartilage defects |
| 06/28/2007 | US20070148241 Use of an intermediate for controlling the release profile of an oral formulation of a medicament |
| 06/28/2007 | US20070148240 Oral formulation containing itraconazole and methods for manufacturing and using the same |
| 06/28/2007 | US20070148239 Loading one or more drugs in a solution onto one or more ion exchange resin particles to form a drug-loaded resin particle which is separated from the solution and dried before recombining the drug-loaded resin particle with the solution to load more drugs onto the drug-load; controlled release |
| 06/28/2007 | US20070148238 Dosage forms for movement disorder treatment |
| 06/28/2007 | US20070148237 Sustained-release formulation of zonisamide |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148235 Pharmaceutical composition |
| 06/28/2007 | US20070148234 Modified release formulation of fenofibric acid in a hydroxypropyl methylcellulose matrix; in vitro dissolution is substantially independent of the dissolution media ionic strength |
| 06/28/2007 | US20070148233 Pharmaceutical formulations of fenofibrate having improved bioavailability |
| 06/28/2007 | US20070148232 Stabilized pharmaceutical solid compositions of low-solubility drugs and poloxamers, and stabilizing polymers |
| 06/28/2007 | US20070148231 Fast-disintegrating tablets |
| 06/28/2007 | US20070148230 Medicament-containing particle and a solid preparation containing the particle |
| 06/28/2007 | US20070148229 Tablet with coloured core |
| 06/28/2007 | US20070148228 Bioavailability; absorption; using a fatty acid, or salt thereof, or fatty ester ; sustained release; histone deacetylase inhibitor |
| 06/28/2007 | US20070148227 Physically/molecularly distributed and/or chemically bound medicaments in capsule shells |
| 06/28/2007 | US20070148226 Mahonia aquifolim extract, extraction process and pharmaceutical composition containing the same |
| 06/28/2007 | US20070148225 PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| 06/28/2007 | US20070148224 Skin treatment compositions containing copper-pigment complexes |
| 06/28/2007 | US20070148223 Skin treatment compositions containing copper-pigment complexes |
| 06/28/2007 | US20070148222 Skin treatment compositions containing copper-pigment complexes |
| 06/28/2007 | US20070148221 Method of producing lipid complexed camptothecin-carboxylate |
| 06/28/2007 | US20070148220 Liposomes and liposomal compositions for vaccination and drug delivery |
| 06/28/2007 | US20070148219 Liposomal Nanowater-Containing Patch-Type Nanodermal Gel for Transdermal Delivery and Method for Preparing the Same |
| 06/28/2007 | US20070148218 Olanzapine containing transdermal drug delivery compositions |
| 06/28/2007 | US20070148217 Percutaneous absorption type cerebral protective agent |
| 06/28/2007 | US20070148216 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 06/28/2007 | US20070148213 Film containing compositions |
| 06/28/2007 | US20070148211 Processes for making particle-based pharmaceutical formulations for oral administration |
| 06/28/2007 | US20070148208 Anti-excititoxic sustained release intracular implants and related methods |
| 06/28/2007 | US20070148207 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/28/2007 | US20070148199 Preparations for topical skin use and treatment |
| 06/28/2007 | US20070148196 Method for producing colloidal nanoparticles with a compounder |
| 06/28/2007 | US20070148195 Compositions and methods for transdermal oxybutynin therapy |
| 06/28/2007 | US20070148194 Novel nanoemulsion formulations |
| 06/28/2007 | US20070148193 Lutein concentrate |
| 06/28/2007 | US20070148192 Stable ophthalmic composition |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |
| 06/28/2007 | US20070148153 Controlled release pharmaceutical compositions for acid-labile drugs |
| 06/28/2007 | US20070148152 Process for the manufacture and use of pancreatin micropellet cores |
| 06/28/2007 | US20070148139 Fabrication of vascularized tissue using microfabricated two-dimensional molds |
| 06/28/2007 | US20070148125 Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 06/28/2007 | US20070148105 Compositions and methods comprising magnetic particles for health use |
| 06/28/2007 | US20070148103 Compositions providing a heating sensation for oral or dermal delivery |
| 06/28/2007 | US20070148100 Nanoparticulate aripiprazole formulations |
| 06/28/2007 | US20070148099 Use of aroma compounds as defoaming agents for ophthalmic solutions with high concentrations of surfactants |
| 06/28/2007 | US20070148098 Sublimable sustained release deiverly system and method of making same |
| 06/28/2007 | US20070148097 Abuse resistant transmucosal drug delivery device |
| 06/28/2007 | DE20122735U1 Verwendung einer Zubereitung für Restenoseprophylaxe Use of a composition for prophylaxis of restenosis |
| 06/28/2007 | DE10335231B4 Verfahren zur Verbesserung der Durchlässigkeit der menschlichen Haut und Pflaster für die transdermale Zufuhr von Wirkstoffen A method for improving the permeability of human skin and patch for the transdermal delivery of active substances |
| 06/28/2007 | DE102005062270A1 Coated solid material, useful e.g. as powder-inhalant or oral dosage form, comprises a powdery solid material and a coating from a hydrophobic enveloping material |
| 06/28/2007 | CA2824075A1 Combination of r, r-glycopyrrolate, formoterol, and a glucocorticoid for the treatment of inflammatory diseases |
| 06/28/2007 | CA2673005A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 06/28/2007 | CA2634357A1 Pharmaceutical formulation for producing rapidly disintegrating tablets |
| 06/28/2007 | CA2634258A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 06/28/2007 | CA2634059A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 06/28/2007 | CA2633878A1 Water-soluble films comprising low-viscosity alginates |
| 06/28/2007 | CA2633308A1 Formulation |
| 06/28/2007 | CA2633149A1 Solid preparation containing an insulin sensitizer |
| 06/28/2007 | CA2633040A1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 06/28/2007 | CA2632908A1 Ginger extract for inhibiting human drug transporters |
| 06/28/2007 | CA2632039A1 Bursting pellets |
| 06/28/2007 | CA2631823A1 Ginger fraction for inhibiting human cyp enzymes |
| 06/28/2007 | CA2631811A1 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 06/28/2007 | CA2629088A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 06/28/2007 | CA2627238A1 Absorbent article |
| 06/28/2007 | CA2627235A1 Absorbent article |
| 06/28/2007 | CA2626234A1 Compressed solid dosage forms with drugs of low solubility and process for making the same |
| 06/28/2007 | CA2611737A1 Formulations containing glimepiride and/or its salts |
| 06/28/2007 | CA2602042A1 Kit and composition of imidazole with enhanced bioavailability |
| 06/27/2007 | EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 06/27/2007 | EP1800689A1 Liquid preparation of physiologically active peptide |
| 06/27/2007 | EP1800671A1 Use of film-forming hair care polymers and pharmaceutical preparations and patches comprising such polymers |
| 06/27/2007 | EP1800670A1 Micellar drug delivery systems for hydrophobic drugs |
| 06/27/2007 | EP1800669A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/27/2007 | EP1800668A1 Process for the manufacture of particles containing antibotics and their application |
| 06/27/2007 | EP1800667A1 Rapidly solubilizing ibuprofen granulate |
| 06/27/2007 | EP1800666A1 Nanoparticulate compositions of angiogenesis inhibitors |
| 06/27/2007 | EP1800665A2 Submicron liposome suspensions obtained from preliposome lyophilizates |
| 06/27/2007 | EP1800664A1 Pharmaceutical formulations for parenteral administration comprising epothilone |